Navigation Links
Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
Date:11/10/2008

ursuant to which Caliper will sublease approximately 10,000 square feet of manufacturing and office space to SOTAX on a market-rate basis starting in 2009.

-- Caliper Completed a Restructuring into Three Strategic Business Units to Sharpen Focus on Core Product Lines. During the third quarter, Caliper reorganized its various products and services along three core business areas -- Discovery Research (Research), Optical Molecular Imaging (Imaging), and Caliper Discovery Alliances and Services (CDAS) -- with the goal of creating a more scalable infrastructure while putting increased focus on growth and profitability.

-- Research is responsible for utilizing Caliper's core automation and microfluidic technologies to address an expanding array of opportunities in drug discovery and life science research, including molecular biology sample preparation for genomics, proteomics, cellular screening and forensics.

-- Imaging is responsible for expanding Caliper's global leadership position in the high growth optical molecular imaging market through expansion of therapeutic area applications of Caliper's IVIS(R) imaging platform, addressing critical discovery workflows and facilitating additional imaging modalities.

-- CDAS is responsible for expanding drug discovery collaborations and alliances, and increasing sales of drug discovery services. The focus of CDAS is to capitalize on market "outsourcing" trends and to maximize the large contract opportunity with the Environmental Protection Agency under its ToxCast screening program.

-- Reduced Operating Costs and Increased Productivity. The company benefited from cost savings initiatives implemented over the previous twelve months, including actions taken in the third quarter.

-- Upon the closing of the PDQ sale, approximately 23 Caliper employees transferred their employment positions to SOTAX. The total estimated annual cost associated with these employees is approximately $2.0 milli
'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
2. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
3. Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays
4. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
5. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
6. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
7. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
8. Caliper Life Sciences Reports Second Quarter 2008 Results
9. Caliper Life Sciences Second Quarter 2008 Financial Results Conference Call Notice
10. Caliper Life Sciences Added to Russell 3000(R) Index
11. Caliper Life Sciences to Present at Deutsche Banks 33rd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/v7fdpx/argentina ) has announced ... - Growth, Trends & Forecasts (2014-2020)" report to ... market is estimated at $0.17 billion by 2018 at ... The near future will bring Biomedical sensors that ... These sensors can be set to trigger alerts when ...
(Date:8/31/2015)... Aug. 31, 2015 Research and Markets ( ... "Israel Biomedical Sensors Market - Growth, Trends & Forecasts ... The Israel Biomedical Sensors market is estimated at $0.19 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
(Date:8/31/2015)... , Aug. 31, 2015  For people with ... brighten their day. The biotechnology company, located in the ... one of the best potential therapies yet for people ... entitled, " Correction of Down syndrome and Edwards syndrome ... journal DNA Research . Elixirgen plans to develop ...
(Date:8/31/2015)... Aug. 31, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapies primarily in the ... the 30-day review period following the filing of ... indications with the U.S. Food and Drug Administration ... active. Logo -  http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
Breaking Biology Technology:Argentina Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts 2014-2020 2Israel Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020 2New Down syndrome therapy discovered 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4
... Quarter-to-Quarter Revenue Gain Evidences Start of Turnaround ... for Core Business ... Agreements, IRVING, Texas, Aug. 14 Carrington,Laboratories, Inc. (Nasdaq: CARN ) reported ... in the year ago,period. The revenue in the quarter just ended, while 17 percent ...
... Summertime equals fun for a lot of,folks. ... (IBS), typical,summer fare could also mean aggravating their ... for IBS," has more on,what people with IBS ... IBS from,ruining their celebrations. Listen to this ...
... Medical,Technologies, Inc. (the "Company") (Nasdaq: CMED ), ... and markets advanced in-,vitro diagnostic products and high ... it will participate in the Morgan,Stanley,s 2007 China ... Date: August 21, 2007 China Medical Technologies, ...
Cached Biology Technology:Carrington Reports Second Quarter 2007 Results 2Carrington Reports Second Quarter 2007 Results 3Carrington Reports Second Quarter 2007 Results 4Carrington Reports Second Quarter 2007 Results 5Carrington Reports Second Quarter 2007 Results 6Carrington Reports Second Quarter 2007 Results 7
(Date:8/5/2015)... 2015 The biosensors market is proving highly ... into newer sectors, and development of devices resulting in ... has seen the entry of multiple participants each year ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... the Global Biosensors Market ( http://www.frost.com/nee9 ), finds ...
(Date:7/31/2015)... Den 10. internationale konference om Genomik (ICG-10, ... - 25. oktober i Shenzhen , ... i år. Siden starten i 2006 er ICB blevet ... og er en af de mest dynamiske, entusiastiske og ... nylige gennembrud og fremskridt inden for ,omik,-forskning, som yderligere ...
(Date:7/31/2015)... de 2015 La 10 th International Conference ... de BGI del 22 al 25 de octubre de 2015 en ... año, la conferencia celebra su décimo aniversario. Desde su inauguración ... de las reuniones anuales más influyentes del mundo en el ... dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... release is available in French . ... and dosage of antipsychotics may influence their efficacy, reported Philippe ... mentale de Montral and Universit de Montral. The efficacy of ... get into the bloodstream after being absorbed. Vincent and Kouassi ...
... healthy and then we weaken and die - that,s probably how ... the phenomenon of ageing shows an unexpected diversity of patterns and ... Denmark. Not all species weaken and become more likely ... likely to die with age, while others are not affected by ...
... The Children,s Hospital of Philadelphia have manipulated key biological ... of hemoglobin normally absent after the newborn period. Because ... in sickle cell disease (SCD), the cell culture findings ... the debilitating blood disorder. "Our study shows ...
Cached Biology News:How can we improve the efficacy of antipsychotics in the era of personalized pharmacotherapy? 2Surprising diversity in aging revealed in nature 2Surprising diversity in aging revealed in nature 3Flipping a gene switch reactivates fetal hemoglobin, may reverse sickle cell disease 2
Mouse Laminin-1 MAb (Clone AL-3)...
IEX-1 S/L (H-20)...
... reactivity with rat (100%), mouse ... pig (48%). Slight reactivity ... confirmed by Western blot versus ... Gia-1, Gia-2, rat Gia-3, bovine ...
IgG2b, k APC clone A95-1, Isotype Rat IgG2b, kappa, 0.1 mg ....
Biology Products: